In addition, the expression of MEIOB was positively correlated with the genome-wide burden of focal copy number aberrations (CNAs) among samples from 10 cancer types with MEIOB and SPATA22 activation (Spearman's rank correlation coefficient=0.12, P=8.30 × 10−14). The gene discussed is SPATA22; the disease is cancer.